Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer

Fig. 1

The distribution of three tumor markers in healthy control (n = 20) and NSCLC patients (GPS 0 n = 95; GPS 1 n = 32; GPS 2 n = 11). A: cytokeratin 19 fragment (CYFRA21-1) concentration was significant deferent between four groups (P<0.05); B: carcinoembryonic antigen (CEA) concentration was significant deferent between four groups (P<0.05); C: tissue polypeptide specific antigen (TPS) concentration was significant deferent between four groups (P<0.05)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us